PANDA of bulk mRNA was previously used to identify the TF co-regulation that existed in triple-negative breast cancer [17] as well as potential biomarkers for anti-angiogenesis treatment in ovarian cancer [16]. The gene discussed is TF; the disease is ovarian cancer.